APDN - Applied DNA Sciences Inc Expected Profit

Corporate company logo of Applied DNA Corp (APDN)

Steady demand for PCR components makes the Applied DNA Sciences (APDN) business resilient to macroeconomic fluctuations. Future profitability metrics visualize this trend, where the value of determines this level. DNA tagging systems designed to protect global supply chains from counterfeiting, along with strict compliance with environmental regulations when handling laboratory reagents, further strengthen the foundation.

APDN: Applied DNA Corp Company Profit Forecast 07/04/2022 - 11/16/2026

Analytical breakdowns for Applied DNA Sciences (APDN)

Fundamental company valuation:Applied DNA, APDN
Finished products of Applied DNA Corp

A fundamental stress test of positions requires separating market noise from actual capitalization growth. Applied DNA Sciences (APDN) is developing genetic material synthesis and molecular brand protection. This indicator aggregates net profit forecasts, allowing for an assessment of the LinearDNA technology's monetization rates through the company's expected financial results. Growth in this metric confirms the expansion of the contract portfolio, while positive momentum signals the business's transition toward sustainable profitability.

Competing companies

Expected Profit Tempus AI|Projected Future Earnings Qiagen|Projected Future Earnings IONS|Expected Profit RGEN (Repligen Corp.)|Avidity - Future Profit|CRSP (crisprtx.com) - Forward Earnings|WGS: Future Profit|Projected Net Profit Ultragenyx (RARE)|BEAM: Projected Future Earnings|Sarepta Therapeutics, Inc. (SRPT) - Projected Future Earnings|TWST (twistbioscience.com) - Projected Future Earnings|10x Genomics, Inc. (TXG) - Company Profit Forecast|Future Profit NTLA (Intellia Therapeutics, Inc.)|STOK - Expected Net Profit|Expected Profit biolifesolutions.com BLFS|Company Profit Forecast Wave Life Sciences Corp (WVE)|MAZE - Expected Profit|Expected Net Income SION (Sionna Therapeutics Inc)|PRME: Projected Future Earnings|Taysha - Expected Net Income|Expected Profit uniQure NV|Net Profit Forecast MGTX (MeiraGTx PLC)|Future Profit RGNX (regenxbio.com)|Solid Biosciences Inc. - Net Profit Forecast|Expected Profit Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Expected Net Profit|BNTC - Expected Profit|Design Pharma - Future Net Profit|RCKT (Rocket Pharmaceuticals Inc) - Future Profit|4D Molecular Therapeutics (FDMT) - Projected Future Earnings|Expected Profit Lexeo Therapeutics, Inc.|Expected Net Profit Korro Bio, Inc. KRRO|Projected Future Earnings EDIT|Company Profit Forecast Silence Therapeutics Corp|Expected Profit proqr.com PRQR|CDXS - Future Profit|SGMO - Expected Profit|Projected Net Profit Nautilus Biotechnology, Inc. (NAUT)|MGX: Projected Future Earnings|Net Profit Forecast DTIL|GBIO (Generation Bio) - Projected Future Earnings|Net Profit Forecast BOLD (boundlessbio.com)|Future Profit XCUR (exicuretx.com)|Celsion Corporation - Net Profit Forecast|Projected Future Earnings PHIO (phiopharma.com)|Projected Future Earnings Mustang Bio, Inc. MBIO|RNAZ: Future Profit|BNGO (Bionano Genomics) - Net Profit Forecast|BLUE (bluebirdbio.com) - Future Profit|Net Profit Forecast IPA|OMGA (omegatherapeutics.com) - Projected Future Earnings|Singular Genomics Systems Inc (OMIC) - Company Profit Forecast|Projected Future Earnings RGLS|Company Profit Forecast Syros Pharmaceuticals, Inc.|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings